-
2
-
-
0031771235
-
-
M. Adams, A.H. Calvert, J. Carmichael, P.I. Clark, R.E. Coleman, H.M. Earl, C.J. Gallagher, T.S. Ganesan, M.E. Gore, J.D. Graham, P.G. Harper, G.C. Jayson, S.B. Kaye, J.A. Ledermann, R.J. Osborne, T.J. Perren, C.J. Poole, J.A. Radford, G.J. Rustin, M.L. Slevin, J.F. Smyth, H. Thomas, and P.M. Wilkinson Br. J. Cancer 78 1998 1404
-
(1998)
Br. J. Cancer
, vol.78
, pp. 1404
-
-
Adams, M.1
Calvert, A.H.2
Carmichael, J.3
Clark, P.I.4
Coleman, R.E.5
Earl, H.M.6
Gallagher, C.J.7
Ganesan, T.S.8
Gore, M.E.9
Graham, J.D.10
Harper, P.G.11
Jayson, G.C.12
Kaye, S.B.13
Ledermann, J.A.14
Osborne, R.J.15
Perren, T.J.16
Poole, C.J.17
Radford, J.A.18
Rustin, G.J.19
Slevin, M.L.20
Smyth, J.F.21
Thomas, H.22
Wilkinson, P.M.23
more..
-
4
-
-
0023718503
-
-
B.L. Zidar, S. Green, H.I. Pierce, R.W. Roach, S.P. Balcerzak, and L. Militello Invest. New Drugs 6 1988 223
-
(1988)
Invest. New Drugs
, vol.6
, pp. 223
-
-
Zidar, B.L.1
Green, S.2
Pierce, H.I.3
Roach, R.W.4
Balcerzak, S.P.5
Militello, L.6
-
9
-
-
0026550682
-
-
S.L. Bruhn, P.M. Pil, J.M. Essigmann, D.E. Housman, and S.J. Lippard Proc. Natl. Acad. Sci. U.S.A. 89 1992 2307
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 2307
-
-
Bruhn, S.L.1
Pil, P.M.2
Essigmann, J.M.3
Housman, D.E.4
Lippard, S.J.5
-
11
-
-
0021894582
-
-
A.M. Fichtinger-Schepman, J.L. van der Veer, J.H. den Hartog, P.H. Lohman, and J. Reedijk Biochemistry 24 1985 707
-
(1985)
Biochemistry
, vol.24
, pp. 707
-
-
Fichtinger-Schepman, A.M.1
Van Der Veer, J.L.2
Den Hartog, J.H.3
Lohman, P.H.4
Reedijk, J.5
-
13
-
-
0029821230
-
-
N. Poklar, D.S. Pilch, S.J. Lippard, E.A. Redding, S.U. Dunham, and K.J. Breslauer Proc. Natl. Acad. Sci. U.S.A. 93 1996 7606
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 7606
-
-
Poklar, N.1
Pilch, D.S.2
Lippard, S.J.3
Redding, E.A.4
Dunham, S.U.5
Breslauer, K.J.6
-
17
-
-
0026764945
-
-
V. Murray, H. Motyka, P.R. England, G. Wickham, H.H. Lee, W.A. Denny, and W.D. McFadyen J. Biol. Chem. 267 1992 18805
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 18805
-
-
Murray, V.1
Motyka, H.2
England, P.R.3
Wickham, G.4
Lee, H.H.5
Denny, W.A.6
McFadyen, W.D.7
-
19
-
-
0037066610
-
-
M.D. Temple, P. Recabarren, W.D. McFadyen, R.J. Holmes, W.A. Denny, and V. Murray Biochim. Biophys. Acta 1574 2002 223
-
(2002)
Biochim. Biophys. Acta
, vol.1574
, pp. 223
-
-
Temple, M.D.1
Recabarren, P.2
McFadyen, W.D.3
Holmes, R.J.4
Denny, W.A.5
Murray, V.6
-
20
-
-
67651095854
-
-
M.J. Cairns, M. Carland, W.D. McFadyen, W.A. Denny, and V. Murray J. Inorg. Biochem. 103 2009 1151
-
(2009)
J. Inorg. Biochem.
, vol.103
, pp. 1151
-
-
Cairns, M.J.1
Carland, M.2
McFadyen, W.D.3
Denny, W.A.4
Murray, V.5
-
21
-
-
77953621169
-
-
M. Carland, M.J. Grannas, M.J. Cairns, V.J. Roknic, W.A. Denny, W.D. McFadyen, and V. Murray J. Inorg. Biochem. 104 2010 815
-
(2010)
J. Inorg. Biochem.
, vol.104
, pp. 815
-
-
Carland, M.1
Grannas, M.J.2
Cairns, M.J.3
Roknic, V.J.4
Denny, W.A.5
McFadyen, W.D.6
Murray, V.7
-
25
-
-
0013462065
-
-
R.K. Moyzis, J.M. Buckingham, L.S. Cram, M. Dani, L.L. Deaven, M.D. Jones, J. Meyne, R.L. Ratliff, and J.R. Wu Proc. Natl. Acad. Sci. U.S.A. 85 1988 6622
-
(1988)
Proc. Natl. Acad. Sci. U.S.A.
, vol.85
, pp. 6622
-
-
Moyzis, R.K.1
Buckingham, J.M.2
Cram, L.S.3
Dani, M.4
Deaven, L.L.5
Jones, M.D.6
Meyne, J.7
Ratliff, R.L.8
Wu, J.R.9
-
26
-
-
0029939848
-
-
P.M. Lansdorp, N.P. Verwoerd, F.M. van de Rijke, V. Dragowska, M.T. Little, R.W. Dirks, A.K. Raap, and H.J. Tanke Hum. Mol. Genet. 5 1996 685
-
(1996)
Hum. Mol. Genet.
, vol.5
, pp. 685
-
-
Lansdorp, P.M.1
Verwoerd, N.P.2
Van De Rijke, F.M.3
Dragowska, V.4
Little, M.T.5
Dirks, R.W.6
Raap, A.K.7
Tanke, H.J.8
-
33
-
-
0025877161
-
-
M. Ponti, S.M. Forrow, R.L. Souhami, M. D'Incalci, and J.A. Hartley Nucleic Acids Res. 19 1991 2929
-
(1991)
Nucleic Acids Res.
, vol.19
, pp. 2929
-
-
Ponti, M.1
Forrow, S.M.2
Souhami, R.L.3
D'Incalci, M.4
Hartley, J.A.5
-
37
-
-
84872913492
-
-
Cisplatin was purchased from Sigma-Aldrich and was dissolved in DMF to give working stock solutions of 5 mM. The fluorescently-labelled REV-FAM (5′-FAM-AACAGCTATGACCATG-3′) oligonucleotide primer was HPLC purified by the manufacturer, Invitrogen
-
34 This last adjustment permitted a comparison to be made between experiments with different concentrations of the experimental drug.
-
-
-
|